SCHEMBL7012583

SCHEMBL7012583

Cc1ccc(-n2cccc2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.44
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RAB9A P51151 2/20 0.37
BCHE P06276 1/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CNR1 P21554 3/20 0.35
CNR2 P34972 3/20 0.35
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4716198 0.78 TP53 (0.44) L3MBTL1KDM4ENPSR1LMNACYP3A4
SCHEMBL2612166 0.78 NPSR1 (0.47) POLBL3MBTL1KDM4ENPSR1LMNA
SCHEMBL8336546 0.76 IDO1 (0.49) LMNACYP1A2CYP2C19ALDH1A1CYP3A4
SCHEMBL9042286 0.75 ALDH1A1 (0.39) KDM4ENPSR1RAB9ALMNACYP1A2
SCHEMBL9043922 0.75 HPGD (0.41) POLBL3MBTL1KDM4ENPSR1RAB9A
SCHEMBL2592892 0.75 TRPA1 (0.48) POLBL3MBTL1KDM4ENPSR1RAB9A
SCHEMBL11826455 0.75 ALDH1A1 (0.56) KDM4ENPSR1RAB9ALMNACYP1A2
SCHEMBL10913318 0.75 CYP3A4 (0.56) POLBKDM4ENPSR1LMNAALDH1A1
SCHEMBL10829179 0.75 L3MBTL1 (0.41) POLBL3MBTL1RAB9ALMNACYP1A2
SCHEMBL10829175 0.75 ALDH1A3 (0.39) POLBL3MBTL1KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
EP-0480204-B1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor FUJISAWA PHARMACEUTICAL CO (JP) 1996-03-20 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
US-5215994-A Treating or preventing hypertension or heart failure FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-01 US disclosed
US-5210092-A Hypotensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-11 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed
EP-0480204-A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed